Publications

Read the peer-reviewed papers providing the body of evidence to validate the new category of mental health care we’re establishing.

SHOWING 6 OF 13

01 Aug 2026Clinical: TRD
Journal of Affective Disorders
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
View publication
27 Jul 2026Preclinical
ACS Chemical Neuroscience
Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs
View publication
16 Jul 2026Clinical: PTSD
Journal of Psychopharmacology
Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder
View publication
10 Jul 2026Preclinical
Neuropsychopharmacology
Psychedelics produce enduring enhancement of reward responsiveness in male rats
View publication
29 Aug 2025Clinical: PTSD
Psychopharmacology
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.
View publication
03 Mar 2025Clinical: TRD
The Journal of Clinical Psychiatry
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
View publication

See our clinical trials

We encourage you to visit clinicaltrials.gov to learn more about our clinical trials.